Par Drugs and Chemicals Ltd. | Technology
₹95.21
-1.72%
| Par Drugs Stock Comparison:

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 1.0B
Gross Profit 628.4M 62.24%
Operating Income 158.5M 15.70%
Net Income 133.6M 13.23%

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 204.2M
Shareholders Equity 989.7M
Debt to Equity 0.21

Cash Flow Metrics

Operating Cash Flow 113.6M
Free Cash Flow 149.3M

Revenue & Profitability Trend

Par Drugs Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 1.0B 951.1M 951.0M 742.0M 598.8M
Cost of Goods Sold 381.3M 588.8M 664.0M 498.6M 374.4M
Gross Profit 628.4M 362.2M 286.9M 243.4M 224.4M
Operating Expenses 374.9M 71.5M 61.4M 48.0M 30.7M
Operating Income 158.5M 201.6M 145.6M 126.6M 131.6M
Pre-tax Income 179.2M 195.2M 150.8M 127.0M 147.3M
Income Tax 45.6M 50.2M 37.5M 34.9M 31.1M
Net Income 133.6M 145.0M 113.3M 92.1M 116.1M
EPS (Diluted) - ₹11.78 ₹9.21 ₹7.49 ₹9.44

Income Statement Trend

Par Drugs Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 548.6M 596.2M 494.4M 435.6M 411.9M
Non-Current Assets 645.3M 419.9M 394.3M 351.3M 352.0M
Total Assets 1.2B 1.0B 888.7M 786.9M 763.8M
Liabilities
Current Liabilities 165.7M 124.4M 139.9M 148.6M 159.8M
Non-Current Liabilities 38.5M 35.4M 36.4M 39.6M 81.9M
Total Liabilities 204.2M 159.8M 176.3M 188.1M 241.7M
Equity
Total Shareholders Equity 989.7M 856.3M 712.4M 598.8M 522.1M

Balance Sheet Composition

Par Drugs Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 179.2M 195.2M 150.8M 127.0M 147.3M
Operating Cash Flow 113.6M 241.2M 172.9M 36.5M 143.3M
Investing Activities
Capital Expenditures -12.3M -60.7M -74.3M -32.0M -1.3M
Investing Cash Flow -252.4M -58.4M -73.4M -30.2M 507.0K
Financing Activities
Dividends Paid - - - -15.4M -7.7M
Financing Cash Flow 0 0 0 -124.3M 22.5M
Free Cash Flow 149.3M 141.7M 57.4M 44.1M 70.4M

Cash Flow Trend

Par Drugs Key Financial Ratios

No financial ratio data available.

Financial data is updated regularly. All figures are in the company's reporting currency.